Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study.
Saved in:
| Title: | Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study. |
|---|---|
| Authors: | Sposito M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Belluomini L; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Nocini R; Otolaryngology-Head and Neck Surgery Department, University of Verona Hospital Trust, Verona, Italy., Insolda J; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Scaglione IM; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Menis J; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Simbolo M; Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy., Lugini A; Medical Oncology Unit, Azienda Ospedaliera (AO) San Giovanni Addolorata Hospital, Rome, Italy., Buzzacchino F; Medical Oncology Unit, San Giuseppe Moscati Hospital, Taranto, Italy., Verderame F; Section of Oncology, Azienda Ospedaliera (AO) Ospedali Riuniti 'Villa Sofia- V. Cervello', Palermo, Italy., Spinnato F; Section of Oncology, Azienda Ospedaliera (AO) Ospedali Riuniti 'Villa Sofia- V. Cervello', Palermo, Italy., Aprile G; Department of Clinical Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy., Calvetti L; Department of Clinical Oncology, San Bortolo General Hospital, Azienda ULSS8 Berica, Vicenza, Italy., Occhipinti M; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Medical Oncology Department, Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Dei Tumori, Milan, Italy., Marinelli D; Department of Experimental Medicine, Sapienza University, Rome, Italy.; Division of Medical Oncology B, Policlinico Umberto I, Rome, Italy., Veccia A; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy., Lombardo F; Lung Unit, Ospedale Pederzoli, Peschiera del Garda, Verona, Italy., Soto Parra HJ; Medical Oncology, Azienda Ospedaliero Universitaria Policlinico 'G. Rodolico-S. Marco', Catania, Italy., Ferraù F; Department of Medical Oncology, Unità Operativa Complessa (UOC) Oncologia, Taormina, Italy., Savastano C; Medical Oncology Unit, San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy., Porta C; AdRes Health Economics and Outcome Research, Turin, Italy., Pradelli L; AdRes Health Economics and Outcome Research, Turin, Italy., Sicari E; Roche S.p.A., Monza, Italy., Castellani S; Roche S.p.A., Monza, Italy., Malapelle U; Department of Public Health, University Federico II of Naples, Naples, Italy., Novello S; Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy., Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Roma, Italy.; Medical Oncology, Università Cattolica del Sacro Cuore, Roma, Italy., Pilotto S; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy., Milella M; Section of Innovation Biomedicine - Oncology Area, Department of Engineering for Innovation Medicine (DIMI), University of Verona and University and Hospital Trust/Azienda Ospedaliero-Universitaria Integrata (AOUI), Verona, Italy. |
| Source: | Frontiers in oncology [Front Oncol] 2024 Jul 09; Vol. 14, pp. 1436588. Date of Electronic Publication: 2024 Jul 09 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
